Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Mauri, Laura; J. Kereiakes, Dean; W. Yeh, Robert; Driscoll-Shempp, Priscilla; E. Cutlip, Donald; Gabríel Steg, Philippe; T. Normand, Sharon‐Lise; Braunwald, Eugene; D. Wiviott, Stephen; J. Cohen, David; R. Holmes, David; W. Krucoff, Mitchell; Hermiller, James; L. Dauerman, Harold; I. Simon, Daniel; E. Kandzari, David; N. Garratt, Kirk; P. Lee, David; Pow, Thomas; Ver Lee, Peter; J. Rinaldi, Michael; M. Massaro, Joseph

doi:10.1056/nejmoa1409312

Public

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Published in New England Journal of Medicine • Nov 16, 2014

Authors:

Laura Mauri

Dean J. Kereiakes

Robert W. Yeh

Abstract

BACKGROUND: Dual antiplatelet therapy is recommended after coronary stenting to prevent thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain. METHODS: Patients were enrolled after they had undergone a coronary stent procedure in which a drug-eluting stent was...

Subject

Thienopyridine

Medicine

Prasugrel

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!